Shinpoong Pharmaceutical Co., Ltd. (019170.KS) KSC

Currency In KRW

AD

Valuation

Market Cap774.8B
Enterprise Value783.22B
P/E Ratio41.26
PEG Ratio0.05
Price/Sales Ratio1.83
Price/Book Ratio1.53
Enterprise/Revenue1.84
Enterprise/EBITDA8.63

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.04
Operating Margin0.07
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.04

Income Statement

Revenue234.68B
Revenue/Share4,353.8
Gross Profit102.37B
EBITDA25.65B
Net Income8.83B
Diluted EPS172

Balance Sheet

Total Cash76.6B
Total Cash/Share1,426.45
Total Debt54.51B
Total Debt/Equity0.19
Current Ratio3.2
Book Value Per Share5,442.5

Price History

52-Week Change-42.82
52-Week High16,300
52-Week Low7,900
Moving Average 50 Days10,612
Moving Average 200 Days12,418.65

Statistics

Average Volume343,820
Shares Outstanding51.71M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor26:25
Last Split DateDecember 29, 2014
AD